Bridgewater Associates LP Sells 8,266 Shares of Chemed Co. (NYSE:CHE)

Bridgewater Associates LP lessened its position in Chemed Co. (NYSE:CHE) by 28.7% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 20,556 shares of the company’s stock after selling 8,266 shares during the period. Bridgewater Associates LP owned approximately 0.14% of Chemed worth $12,354,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. SG Americas Securities LLC increased its stake in Chemed by 422.9% in the second quarter. SG Americas Securities LLC now owns 7,551 shares of the company’s stock valued at $4,097,000 after purchasing an additional 6,107 shares in the last quarter. Harbor Capital Advisors Inc. increased its stake in Chemed by 292.7% in the second quarter. Harbor Capital Advisors Inc. now owns 1,241 shares of the company’s stock valued at $673,000 after purchasing an additional 925 shares in the last quarter. Hsbc Holdings PLC increased its stake in Chemed by 110.0% in the second quarter. Hsbc Holdings PLC now owns 10,638 shares of the company’s stock valued at $5,801,000 after purchasing an additional 5,572 shares in the last quarter. Evergreen Capital Management LLC bought a new stake in Chemed in the second quarter valued at approximately $7,812,000. Finally, Quest Partners LLC increased its stake in Chemed by 634.3% in the second quarter. Quest Partners LLC now owns 1,990 shares of the company’s stock valued at $1,080,000 after purchasing an additional 1,719 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Analyst Upgrades and Downgrades

CHE has been the subject of several research reports. Royal Bank of Canada lowered their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th. StockNews.com downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research report on Friday, November 22nd.

Chemed Stock Down 0.4 %

Shares of CHE stock opened at $571.31 on Friday. The firm has a fifty day moving average of $578.74 and a 200-day moving average of $565.02. Chemed Co. has a 12-month low of $523.33 and a 12-month high of $654.62. The company has a market capitalization of $8.60 billion, a price-to-earnings ratio of 28.87, a P/E/G ratio of 2.43 and a beta of 0.46.

Chemed (NYSE:CHE) last announced its earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing the consensus estimate of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. During the same quarter in the previous year, the company posted $5.32 EPS. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. On average, equities analysts expect that Chemed Co. will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Monday, November 18th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.35%. The ex-dividend date is Monday, November 18th. Chemed’s payout ratio is 10.11%.

Insider Buying and Selling

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Monday, November 25th. The shares were sold at an average price of $572.77, for a total value of $1,145,540.00. Following the completion of the sale, the chief executive officer now owns 101,735 shares in the company, valued at $58,270,755.95. This trade represents a 1.93 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Nicholas Michael Westfall sold 1,713 shares of the stock in a transaction on Monday, September 9th. The shares were sold at an average price of $569.35, for a total transaction of $975,296.55. Following the completion of the sale, the executive vice president now owns 6,109 shares of the company’s stock, valued at approximately $3,478,159.15. This represents a 21.90 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 6,113 shares of company stock worth $3,557,445. 3.32% of the stock is owned by insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.